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Abstract
Introduction Mammographic density is a strong, independent
risk factor for breast cancer. A critical unanswered question is
whether cancers tend to arise in mammographically dense
tissue (i.e. are densities directly related to risk or are they simply
a marker of risk). This question cannot be addressed by studying
invasive tumors because they manifest as densities and cannot
be confidently differentiated from the densities representing
fibrous and glandular tissue. We addressed this question by
studying ductal carcinoma in situ (DCIS), as revealed by
microcalcifications.
Method We studied the cranio-caudal and the mediolateral-
oblique mammograms of 28 breasts with a solitary DCIS lesion.
Two experienced radiologists independently judged whether the
DCIS occurred in a mammographically dense area, and
determined the density of different areas of the mammograms.
Results It was not possible to determine whether the DCIS was
or was not in a dense area for six of the tumors. Of the remaining
22 lesions, 21 occurred in dense tissue (test for difference from
expected taken as the percentage of density of the
'mammographic quadrant' containing DCIS; P  < 0.0001). A
preponderance of DCIS (17 out of 28) occurred in the
mammographic quadrant with the highest percentage density.
Conclusion DCIS occurs overwhelmingly in the
mammographically dense areas of the breast, and pre-DCIS
mammograms showed that this relationship was not brought
about by the presence of the DCIS. This strongly suggests that
some aspect of stromal tissue comprising the
mammographically dense tissue directly influences the
carcinogenic process in the local breast glandular tissue.
Introduction
On a mammogram fat appears radiolucent or dark, whereas
connective and epithelial tissue appear radiodense or white.
The amount of mammographic density is a strong independent
predictor of breast cancer risk [1-4]. For technical reasons,
mammographic density has usually been expressed as mam-
mographic percentage density (MPD; i.e. the ratio of the area
of the breast that is dense to the total area of the breast on the
mammogram). There is an approximately fivefold increased
breast cancer risk in women with 60% or more MPD as com-
pared with women with under 10% MPD, with a steady
increase in risk with increasing MPD. Studies in which MPD is
used directly have found very similar effects [5-8].
The biological basis for this increased risk for breast cancer
associated with increased mammographic densities is not
understood, and the detailed nature of densities has not been
studied extensively. A fundamental question that has yet to be
answered is whether, within a particular breast, cancers tend
to occur in dense areas or not. Invasive carcinoma is usually
identified as a spiculated dense mass on the mammogram,
and even an expert mammographer is frequently unable to dis-
tinguish this mass from normal dense breast tissue, making it
difficult, and often impossible, to decide whether the tumor
arose in a dense area. We used mammograms obtained from
patients with ductal carcinoma in situ (DCIS), as evidenced
mammographically by microcalcifications, to address this
question. DCIS is a 'nonobligate but definite local precursor of
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invasive carcinoma' [9], which commonly manifests as calcifi-
cations on the mammogram and usually can easily be differen-
tiated from dense breast tissue.
Materials and methods
We retrospectively identified consecutive women diagnosed
with DCIS at the Henrietta C Lee Breast Center at the USC/
Norris Comprehensive Cancer Center, for whom diagnostic
mammograms were available at the Breast Center. There were
31 such patients. The study protocol was approved by the
Institutional Review Board of the University of Southern Cali-
fornia School of Medicine; patient informed consent was not
required for this retrospective study, with minimal risk to
participant.
For each participant we obtained the mammogram(s) of the
affected breast(s) at the time of the DCIS diagnosis, and
whenever available we also obtained the most recent pre-
DCIS mammogram(s). We eliminated four of these women
from further consideration at this stage: one because the
DCIS lesions occurred over a wide area; one because the
radiologists could not decide on the precise location of the
DCIS (see below); and two because the single DCIS lesion
occurred in the subareolar area – an area that is uniformly
dense. Of the remaining 27 women, one had a single DCIS
lesion in both breasts and 26 had a single DCIS lesion in one
breast. These 28 lesions comprise the subject of this report.
The DCIS tumors ranged in size (length) from 0.5 cm to 9.3
cm, and all but four were less than 4 cm. Eleven tumors were
grade 3, eight were grade 2, one was grade 1, and seven were
of unknown grade.
For each affected breast, the cranio-caudal (CC) and medi-
olateral-oblique (MLO) mammographic views were studied.
Based on these two mammograms for each DCIS lesion, the
two expert mammography radiologists (LHL and YRP) inde-
pendently coded the DCIS lesion as to whether it was in an
area of mammographically dense tissue (yes/no/cannot
determine).
The breast images were also divided equally into a lateral and
medial part based on the CC image (CC-L and CC-M, respec-
tively); similarly, the MLO view was divided into a superior and
inferior part (MLO-S and MLO-I, respectively). The radiologists
independently visually assessed the percentage of mammo-
graphically dense tissue for each of the four 'mammographic
areas' (CC-L, CC-M, MLO-S and MLO-I). The MPD for the
whole breast was taken as the average of these four values.
The percentage density of the part of the breast ('mammo-
graphic quadrant') containing the DCIS lesion was estimated
as the average of the two density assessments of the mammo-
graphic areas containing the lesion. For instance, if the DCIS
lesion occurred in the upper outer clinical quadrant of the
breast, then it would be observed in the superior MLO view
and the lateral part of the CC view, and the percentage density
of the DCIS-containing mammographic quadrant would then
be the average density of the CC-L and MLO-S mammo-
graphic areas. The percentage density of the part of the breast
not containing the DCIS lesion was taken as the average of the
remaining two density assessments. It is possible that more
optimal measures of the density of that part of the breast con-
taining, and not containing, the DCIS could be made, but this
simple averaging measure is sufficient for our purposes here
and it is not clear how one would determine a better measure.
Each DCIS lesion was classified as being in dense tissue
(score of 1) or in nondense tissue (score of 0) or not deter-
mined (scored as a missing value). The expected score for a
lesion was taken to be the PMD of the part of the breast con-
taining the DCIS as described above (this was done sepa-
rately for the estimated percentage density, as recorded by the
radiologists individually and as their average values). The total
score for the lesions was compared with the total expected
score using exact methods for combinations of independent
binomial distributions with known expected values. We used
the paired t-test method to test the significance of the differ-
ences between the densities in affected and nonaffected
DCIS areas in a single breast. All P values are two sided.
Results
Table 1 shows the results for our main question of interest,
namely whether DCIS occurs preferentially in mammographi-
cally dense tissue. Of the 28 images, radiologists 1 and 2
agreed on the rating for 24 of them: 21 as being in dense tis-
sue, one as being in nondense tissue, and two as being asso-
ciated with a part of the mammogram where the lesion was too
closely associated with both dense and nondense tissue to be
able to make an assignment confidently. Of the remaining four
lesions, radiologist 2 was not willing to make a call on three of
them whereas radiologist 1 felt that the lesion was in dense tis-
sue, and there was a single lesion in which the two radiologists
disagreed (radiologist 1 called it in nondense tissue whereas
radiologist 2 called it as being in dense tissue). Of the 22
informative lesions with agreement between radiologists, 21
were called as being in dense areas (observed 21; expected
10.75 based on the assessment by radiologist 1, 10.77 based
on the assessment by radiologist 2, and 10.76 for their aver-
age; P < 0.0001 using any of the three expected values).
Table 2 shows the average density (for the two radiologists
combined) and the number of DCIS lesions by mammographic
area (CC-M, CC-L, MLO-S and MLO-I). Of the 28 lesions, 17
occurred in the lateral-superior mammographic quadrant,
whereas only two occurred in the medial-inferior mammo-
graphic quadrant. This correlated strongly with the average
percentage density in the different mammographic quadrants,
which varied from 55.8% in the lateral-superior mammo-
graphic quadrant (i.e. average of densities in the CC-L and
MLO-S) to 38.3% in the medial-inferior mammographic quad-
rant (i.e. average of densities in the CC-M and MLO-I). NotAvailable online http://breast-cancer-research.com/content/7/5/R605
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surprisingly, we also found significant differences in densities
between the lateral (n = 21) and medial (n = 7) areas of the
mammographic CC view (51.3% for CC-L versus 33.5% for
CC-M), and between the superior (n = 22) and the inferior (n
= 6) areas of the MLO view (47.6% for MLO-S versus 34.7%
for MLO-I). These two mammographic views are highly corre-
lated; for example, the correlation between the percentage
densities of the CC-L area and the MLO-S area was 0.93.
We also considered tumor grade and tumor size in our analy-
sis. We found no clear association between tumor grade and
percentage density, and the results were essentially
unchanged when we excluded the four women with tumors
greater than 4 cm (data not shown).
Discussion
The findings of this study show that DCIS occurs overwhelm-
ingly in the areas of the breast that are mammographically
dense. We identified previous mammograms showing no
DCIS for 13 of the 21 mammograms with DCIS in a dense
area; all 13 showed that the areas subsequently showing
DCIS were clearly dense at the time of the earlier
mammogram.
Our results further show that DCIS occurs in the part of the
breast that has the highest percentage density on the mammo-
gram, namely the lateral-superior mammographic view.
Although the difference in densities between the lateral-supe-
rior and the medial-lower mammographic quadrants (55.8%
versus 38.3%) is highly statistically significant (P < 0.0001),
the magnitude of the difference does not mirror the difference
in frequency of DCIS and suggests that the amount of mam-
mographically dense tissue is not the only component of the
breast that plays a key role in the carcinogenic process.
Mammographic density is a very strong risk factor for breast
cancer. The findings reported here suggest that this is a direct
causal connection between the dense tissue and the breast
glandular tissue. One possible biological basis for this would
be that breast glandular tissue is overwhelmingly concentrated
in the (mammographically) dense areas of the breast.
Although, in our experience, this is generally believed to be
true, there are surprisingly few data on this, and a recent study
[10] found no correlation between the amount of glandular tis-
sue in a breast and the mammographic density of the breast.
There is much evidence from studies in rodents of a complex
interaction between breast stroma and epithelial tissue [11],
and increased epithelial cell proliferation secondary to
increased density could explain why mammographic density is
associated with an increased risk for epithelial malignancy.
Mammographic densities are themselves changed by inter-
ventions that affect breast cancer risk. Selective estrogen
receptor modulators reduce breast cancer risk and reduce
densities [12-14], and estrogen–progestin replacement
therapy increases breast cancer risk and increases densities
[15,16]. The interaction between the stroma and the epithe-
lium may therefore be two way.
Table 1
Relation of DCIS lesion to dense tissue
Radiologist 2
Dense Nondense Cannot determine
Radiologist 1 Dense 21 1 0
N o n d e n s e 010
Cannot determine 3 0 2
DCIS, ductal carcinoma in situ.
Table 2
Average mammographic density and location of DCIS by 'mammographic quadrant' of the breast
Mammographic quadrant
CC MLO Density (%; mean ± SE) Number of DCIS lesions
LS 5 5 . 8  ±  4 . 2 1 7
MS 4 7 . 9  ±  4 . 0 5
LI 4 6 . 2  ±  4 . 0 4
MI 3 8 . 3  ±  4 . 0 2
CC, cranio-caudal; DCIS, ductal carcinoma in situ; I, inferior; L, lateral; M, medial; MLO, mediolateral-oblique; S, superior; SE, standard error.Breast Cancer Research    Vol 7 No 5    Ursin et al.
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Conclusion
Much remains to be learned, but this study shows that it is the
nature of the interaction between stromal and epithelial tissue
that should be the major focus of breast cancer research.
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